查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1870586

抗病毒涂层市场：按技术、应用、终端用户产业、类型和分销管道划分－2025-2032年全球预测

Antiviral Coatings Market by Technology, Application, End User Industry, Form, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，抗病毒涂层市场规模将达到 65.4 亿美元，复合年增长率为 7.39%。

关键市场统计数据
基准年 2024 36.9亿美元
预计年份：2025年 39.7亿美元
预测年份 2032 65.4亿美元
复合年增长率 (%) 7.39%

本执行摘要以富有远见的引言开篇，将抗病毒涂层定位为一个新兴领域，它将材料科学的进步与运营和监管现实相结合，使其成为一个多学科交叉且商业性日趋成熟的类别。

本执行摘要首先简要概述了抗病毒涂层这一新兴领域，它融合了尖端材料科学、表面工程和公共卫生需求。抗病毒涂层包含旨在减少接触表面活病毒数量的功能性组合药物和基材，目前正引起产品开发人员、设施管理人员和监管机构的广泛关注。该领域已从早期的学术示范阶段发展成为商业化产业，性能检验、法规遵从性和可製造性正推动着技术选择超越试点阶段。

技术创新融合、监管日益严格以及买家期望如何从根本上重塑抗病毒涂层的应用路径和竞争格局

由于技术进步、监管日益严格以及客户期望不断变化，该行业正经历变革。奈米材料和表面化学领域的创新正在拓展配方师可用的工具箱，从而实现以接触灭活、长期持久性和与现有基质的整合为优先的靶向抗病毒机制。同时，标准和测试通讯协定也变得更加严格和统一，这使得检验的性能数据和第三方认证流程的重要性日益凸显。因此，产品的差异化越来越依赖可证明的耐久性、安全性以及与下游生产製程的兼容性。

检验了美国新加征的关税对整个抗病毒涂料价值链的供应链策略、供应商选择和製造地在地化选择的累积影响。

2025年实施的关税和贸易政策调整正在产生累积效应，重塑整个抗病毒涂料生态系统的采购决策和供应商策略。关税变化提高了进口前体材料和特种添加剂的实际成本，迫使配方师和製造商重新评估原材料的可替代性，探索替代供应商的选择，并重组采购框架以实现成本透明化。此外，关税也会影响资本计划的投资回收期计算，从而改变国内製造投资的相对吸引力。权衡本地生产与全球采购的企业将面临重新评估的成本效益矩阵。

深度細項分析，揭示技术差异、应用需求、产业要求、产品形式和分销管道如何共同决定商业性可行性。

细分市场层面的趋势揭示了不同材料、应用、产业、产品形态和通路各自独特的发展轨迹，这些因素共同塑造了产品的采用模式和商业化复杂性。在技​​术层面，成熟的金属基方法（例如铜离子和银离子）与不断发展的碳基解决方案并存，后者包括光催化二氧化钛变体和多种具有不同表面化学性质和加工要求的石墨烯衍生物。二氧化钛本身存在两种多晶型，这会影响其光催化效率和配方行为。同时，碳基石墨烯衍生物提供了频谱片状、氧化态和还原态，这些形态具有不同的分散性和界面性质。这些技术上的细微差别直接影响阻隔性能、病毒灭活率以及与基材製造的兼容性。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和监管重点将影响采购偏好、生产选择和商业化路径。

区域趋势为开发商、供应商和最终用户带来了不同的机会和风险。在美洲，需求中心正着力发展医疗基础设施、机构采购标准，日益重视本地製造，以降低全球物流中断带来的风险。因此，拥有透明供应链和可靠业绩的供应商更受青睐，更容易获得大型合约；同时，与本地製造商的创新合作也得到推广，以缩短前置作业时间并符合公共采购法规。

企业竞争与合作的动态：现有製造商、专业创新者与製造伙伴携手合作，推动抗病毒涂层的商业化进程。

竞争格局由成熟的化学、特种涂料配方商、尖端材料Start-Ups以及为下游整合商提供契约製造服务的製造商组成。现有材料供应商利用其规模和现有分销网络，推动面向大批量应用的配方研发；而特种配方商和Start-Ups则专注于差异化的性能属性，例如持续的抗病毒功效或与敏感基材的兼容性。契约製造製造商和涂料代工服务商拥有强大的规模化生产能力，使创新者无需大量资本投入即可从实验室演示阶段过渡到中试和大规模生产。

为行业领导者提供实用建议，以整合检验严谨性、供应商韧性、跨职能产品开发和法规遵从性，从而推动可扩展的商业化。

产业领导者应优先考虑平衡策略，将材料创新与务实的供应链和监管策略结合。首先，为支援性能声明，需要投资建设完善的检验框架，包括第三方测试、标准化挑战性通讯协定和耐久性测试。此类投资将减少采购部门和监管机构的实施障碍，并建立起足以抵御竞争对手声明的差异化优势。其次，为降低贸易政策波动和物流瓶颈带来的风险，应促进策略供应商多元化，并儘快对替代原料来源进行资格认证。双重采购和区域伙伴关係将降低单一故障点带来的脆弱性，并确保向关键客户提供合格的供应。

为了确保分析的严谨性，我们采用透明、多方面的调查方法，结合与关键相关人员的访谈、实验室检验、文献和专利分析以及情境测试。

我们的调查方法融合了定性和定量证据，旨在对抗菌涂层领域进行稳健且可重复的分析。主要研究包括对来自多个终端应用领域的材料科学家、产品经理、采购人员和法规专家进行结构化访谈。这些访谈深入剖析了实际限制、认证时间表和供应商选择标准，并辅以实验室检验研究，在模拟使用条件下评估耐久性指标、病毒灭活机制和基材相容性。

我们的策略结论强调，检验的性能、供应链的韧性和监管合规性是决定抗病毒涂层长期成功的关键因素。

总之，抗病毒涂层正从研究主导的探索性领域转向一系列具有商业性可行性的解决方案，这需要材料科学、法规遵循和供应链策略的精心协调。儘管正在开发的技术具有不同的作用机制和性能特征，但其商业性成功将取决于已证实的有效性、可製造性以及采购和监管相关人员的认可。积极解决测试透明度、供应商韧性和特定应用限制的公司将更有利于抓住机构机会并负责任地扩大规模。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 利用可见光活化奈米复合材料开发光敏抗病毒涂层，以实现持续的表面消毒
  • 透过在公共交通工具的内表面整合耐用的抗病毒聚合物涂层来减少病毒传播。
  • 透过采用源自几丁聚醣和其他天然聚合物的生物基抗病毒涂层实现永续保护
  • 推出具有自修復功能的抗病毒涂层，即使在高人流量环境中经受磨损和刮擦后，也能恢復其有效性。
  • 在抗病毒涂层配方中使用金属氧化物奈米颗粒，可实现频谱活性并提高耐久性。
  • 协调监管工作，制定全球抗病毒涂层功效测试和认证通讯协定。
  • 具有生物相容性和可消毒性能特征的客製化抗病毒涂层，适用于医疗设备表面
  • 透明抗病毒涂层已应用于消费性电子产业，可在不影响触控萤幕灵敏度的前提下进行消毒。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按技术分類的抗病毒涂层市场

  • 铜
  • 石墨烯基
    • 石墨烯奈米微片
    • 氧化石墨烯
    • 还原氧化石墨烯
  • 季铵化合物
  • 银离子
  • 二氧化钛
    • 锐钛矿
    • 金红石

第九章 按应用分類的抗病毒涂层市场

  • 家用电子电器
  • 食品/饮料包装
  • 卫生保健
  • 空调系统
  • 运输

第十章：以终端用户产业分類的抗病毒涂层市场

  • 航太工业
  • 汽车产业
  • 商业建筑
  • 食品加工厂
  • 医院和诊所
  • 住宅建筑

第十一章 抗病毒涂层市场（按类型划分）

  • 液体涂层
  • 粉末涂装
  • 自清洁膜
  • 喷涂

第十二章 抗病毒涂层市场（依通路划分）

  • 直销
  • 经销商
  • 线上零售

第十三章 抗病毒涂层市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 抗病毒涂层市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国抗病毒涂层市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • PPG Industries, Inc.
    • The Sherwin-Williams Company
    • Akzo Nobel NV
    • Dow Inc.
    • BASF SE
    • DuPont de Nemours, Inc.
    • RPM International Inc.
    • Nippon Paint Holdings Co., Ltd.
    • Kansai Paint Co., Ltd.
    • Axalta Coating Systems Ltd.
Product Code: MRR-1A1A064C01F3

The Antiviral Coatings Market is projected to grow by USD 6.54 billion at a CAGR of 7.39% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.69 billion
Estimated Year [2025] USD 3.97 billion
Forecast Year [2032] USD 6.54 billion
CAGR (%) 7.39%

A forward-looking introduction that frames antiviral coatings as a multidisciplinary, commercially maturing category linking materials innovation with operational and regulatory realities

This executive summary opens with a concise orientation to antiviral coatings as an emergent category that bridges advanced materials science, surface engineering, and public health imperatives. Antiviral coatings encompass functional formulations and substrates designed to reduce viable viral loads on contact surfaces, and they now attract intensified interest across product developers, facility managers, and regulators. The landscape has evolved beyond early academic demonstrations into a commercializing industry where performance validation, regulatory compliance, and manufacturability determine which technologies advance beyond pilot stages.

Against this backdrop, stakeholders must navigate a matrix of technical attributes, application-specific constraints, and procurement preferences. Material families such as metal-based ions, photocatalysts, and carbon-based nanomaterials each present distinct efficacy mechanisms, durability profiles, and process integration pathways. In turn, application settings-from high-touch points in healthcare environments to integrative layers within consumer electronics-impose different priorities for durability, clarity, and electrical compatibility. This introduction sets the stage for a deeper analysis by framing the primary drivers of adoption, the constraints that limit rapid scale-up, and the cross-functional coordination required to translate laboratory promise into robust, certifiable products.

How converging technological advancements, heightened regulatory rigor, and buyer expectations are fundamentally reshaping adoption pathways and competitive dynamics in antiviral coatings

The sector is undergoing transformative shifts driven by converging technological advances, regulatory scrutiny, and evolving customer expectations. Innovations in nanomaterials and surface chemistry have expanded the toolbox available to formulators, enabling targeted antiviral mechanisms that prioritize contact inactivation, long-term persistence, and integration with existing substrates. At the same time, standards and testing protocols are becoming more rigorous and more harmonized, which elevates the importance of validated performance data and third-party certification pathways. As a result, product differentiation increasingly rests on demonstrable longevity, safety profiles, and compatibility with downstream manufacturing processes.

Parallel to technical progress, procurement behavior has shifted toward resilience and traceability. Buyers are asking tougher questions about supply chain provenance, raw material concentration risks, and supplier capabilities to scale. These concerns have prompted manufacturers to re-evaluate sourcing strategies and to invest in nearshoring, dual-sourcing, and inventory buffering. Moreover, user experience considerations now shape product specifications: end-users expect coatings that preserve aesthetics, do not interfere with touch sensitivity on consumer electronics, and meet hygiene protocols in clinical environments. Taken together, these shifts favor companies that can marry robust science with supply chain confidence and clear regulatory positioning, thereby accelerating the transition from pilot projects to broader commercial adoption.

Examining the cumulative effects of newly instituted United States tariffs on supply chain strategies, supplier qualification, and manufacturing localization choices across the antiviral coatings value chain

The introduction of tariffs and trade policy shifts in 2025 has a cumulative effect that reshapes procurement decisions and supplier strategies across the antiviral coatings ecosystem. Tariff changes raise the effective cost of imported precursor materials and specialized additives, prompting formulators and manufacturers to reassess raw material substitution, qualify alternative suppliers, and retool procurement frameworks to capture cost visibility. In addition, tariffs influence the relative attractiveness of domestic manufacturing investments by altering payback calculations for capital projects; companies weighing localized production against global sourcing now face revised cost-benefit matrices.

In response, some organizations accelerate efforts to qualify alternative chemistries or to reformulate products to reduce dependence on highly tariffed inputs. Others pursue strategic partnerships with regional suppliers that offer stable logistics and regulatory alignment. Furthermore, the tariff environment amplifies the importance of supply chain mapping and scenario planning: organizations that maintain granular visibility into tiered suppliers can more quickly identify contingency sources and adjust lead times. Regulatory agencies and procurement policies also intersect with tariffs, since localized content requirements may become advantageous for public tenders. Overall, the tariff landscape reinforces a broader trend toward supply chain resilience and strategic sourcing, compelling stakeholders to integrate trade policy considerations into R&D roadmaps and commercialization plans.

Deep segmentation insights that decode how technology variants, application demands, industry requirements, product form factors, and distribution channels collectively determine commercial viability

Segment-level dynamics reveal differentiated trajectories across materials, applications, industry verticals, product forms, and distribution pathways, each shaping adoption patterns and commercialization complexity. On the technology front, established metal-based approaches such as copper and silver ions coexist with photocatalytic titanium dioxide variants and evolving carbon-based solutions, including multiple graphene derivatives that differ in their surface chemistry and processing requirements. Titanium dioxide itself presents dual polymorphic considerations that affect photocatalytic efficiency and formulation behavior, while carbon-based graphene derivatives offer a spectrum of platelet, oxidized, and reduced forms with distinct dispersion and interface properties. These technical nuances directly influence barrier properties, viral inactivation kinetics, and compatibility with substrate manufacturing.

Application drivers vary significantly: coatings intended for consumer electronics must balance optical clarity and touch responsiveness, food and beverage packaging requires food-contact safety and minimal sensory impact, healthcare environments prioritize antimicrobial breadth and cleanability protocols, HVAC systems demand coated media that withstand airflow and particulate exposure, and transportation surfaces need abrasion resistance under heavy use. End-user industry pressures also diverge: aerospace and automotive sectors impose stringent qualification cycles and long-term durability expectations, commercial buildings and residential environments emphasize cost-effective maintainability, and food processing and healthcare settings require documented compliance with hygiene standards. Form chemistry affects manufacturing routes and end-use performance, whether delivered as liquids for spray systems, powders for thermal curing, self-cleaning films for retrofit applications, or sprays for rapid onsite deployment. Finally, distribution strategies shape how innovations reach buyers: direct sales favor customized technical support for institutional clients, distributors enable regional stocking and logistics optimization, and online retail expands access to consumer-facing products but raises additional expectations for clear performance claims and certification. When these segmentation dimensions are considered holistically, product development and go-to-market decisions become finely calibrated exercises in trade-offs between performance, cost, manufacturability, and regulatory acceptance.

Regional dynamics and regulatory priorities across the Americas, Europe Middle East and Africa, and Asia-Pacific that shape procurement preferences, manufacturing choices, and commercialization pathways

Regional dynamics create distinct opportunity and risk profiles for developers, suppliers, and end users. In the Americas, demand centers emphasize healthcare readiness, institutional procurement standards, and growing interest in localized manufacturing to reduce exposure to global logistics disruptions. As a result, suppliers that demonstrate transparent supply chains and validated performance see preferential treatment in large contracts, and innovation partnerships with local manufacturers gain traction to shorten lead times and meet public procurement rules.

Across Europe, the Middle East and Africa, regulatory harmonization and sustainability imperatives increasingly shape product requirements. Purchasers in these markets prioritize compliance with chemical safety frameworks and life-cycle considerations, which encourages the development of formulations with reduced environmental impact and simplified end-of-life pathways. Moreover, regional procurement often involves multi-country tendering processes that favor suppliers with established distribution networks and multi-jurisdictional certification experience.

The Asia-Pacific region remains a major hub for both raw material production and large-scale manufacturing, while also hosting rapidly growing end-use demand across consumer electronics and transportation sectors. Stakeholders operating in this region must balance competitive cost structures with rising expectations for product performance and international standards alignment. Across all regions, cross-border regulatory dialogues and bilateral trade arrangements will continue to affect supplier selection and investment decisions, requiring companies to pursue flexible global strategies that accommodate local market nuances and compliance regimes.

Competitive and collaborative company dynamics showing how legacy manufacturers, specialized innovators, and manufacturing partners combine to advance antiviral coating commercialization

Competitive positioning reflects a mix of legacy chemical manufacturers, specialized coating formulators, advanced materials startups, and contract manufacturers that supply downstream integrators. Established materials suppliers leverage scale and existing distribution networks to push formulations into high-volume applications, while specialized formulators and startups focus on differentiated performance attributes such as prolonged antiviral persistence or compatibility with sensitive substrates. Contract manufacturers and toll coaters provide important scale-up capability, enabling innovators to move from bench demonstrations to pilot and production volumes without large capital investments.

Strategic partnerships between materials developers and system integrators accelerate technology validation and market entry by combining formulation expertise with application-domain knowledge. In parallel, larger corporations pursuing vertical integration seek to control key inputs and reduce exposure to upstream volatility. Investment activity increasingly targets firms that can demonstrate reproducible performance validated by accredited test labs, robust safety data, and manufacturing processes that meet industry standards. Success in commercial markets depends on clear articulation of product differentiation, defensible intellectual property, and the ability to support customers through qualification timelines, especially in heavily regulated sectors such as healthcare and aerospace.

Actionable recommendations for industry leaders that align validation rigor, supplier resilience, cross-functional product development, and regulatory engagement to drive scalable commercialization

Industry leaders should prioritize a balanced agenda that aligns material innovation with pragmatic supply chain and regulatory strategies. First, invest in robust validation frameworks that include third-party testing, standardized challenge protocols, and durability studies to substantiate performance claims. These investments reduce adoption friction with procurement teams and regulators, and they create defensible differentiation versus competing claims. Second, pursue strategic supplier diversification and near-term qualification of alternative raw material sources to reduce exposure to trade policy shocks and logistics bottlenecks. Dual-sourcing and regional partnerships will mitigate single-point vulnerabilities and support reliable delivery to key customers.

Third, align product roadmaps with application-specific requirements by embedding cross-functional teams that include materials scientists, process engineers, and end-user representatives. This approach shortens qualification cycles and ensures that coatings meet operational constraints such as clarity for touchscreens, food-contact safety, or resistance to frequent cleaning in clinical settings. Fourth, engage proactively with regulators and standards bodies to help shape realistic testing regimes and to secure early acceptance for novel chemistries. Finally, invest in commercialization capabilities-sales enablement, technical service, and digital channels-to ensure that innovations can be adopted at scale while preserving margins and protecting brand credibility. Together these actions create a resilient commercialization pathway that balances innovation ambition with operational discipline.

A transparent, multipronged research methodology that integrates primary stakeholder interviews, laboratory validation, literature and patent analysis, and scenario testing to ensure analytic rigor

The research methodology combines qualitative and quantitative evidence streams to deliver a robust, reproducible analysis of the antiviral coatings landscape. Primary research consists of structured interviews with materials scientists, product managers, procurement leads, and regulatory experts across multiple end-use sectors. These conversations inform an understanding of practical constraints, qualification timelines, and supplier selection criteria, and they are supplemented by laboratory validation studies that assess durability metrics, viral inactivation mechanisms, and substrate compatibility under simulated use conditions.

Secondary research includes systematic reviews of peer-reviewed literature, patent filings, regulatory guidance documents, and standards published by recognized technical committees. Market-facing intelligence incorporates product datasheets, supplier technical notes, and case studies of implemented coatings across facilities and products. To ensure analytical rigor, the methodology applies cross-validation where laboratory results are compared against reported field performance and independent test outcomes. Scenario analysis explores alternative procurement and trade environments to assess resilience strategies. Throughout, transparency in data sources and clear documentation of assumptions underpin the conclusions, enabling clients to trace insights back to primary evidence and technical validation.

A strategic conclusion emphasizing that validated performance, supply chain resilience, and regulatory alignment are the critical determinants of long-term success for antiviral coatings

In conclusion, antiviral coatings are transitioning from a research-driven curiosity to a commercially relevant suite of solutions that require careful alignment of materials science, regulatory compliance, and supply chain strategy. The technologies under development offer differentiated mechanisms and performance profiles, but their commercial success hinges on validated efficacy, manufacturability, and acceptance by procurement and regulatory stakeholders. Businesses that proactively address testing transparency, supplier resilience, and application-specific constraints will earn a disproportionate share of institutional opportunities and will be better positioned to scale responsibly.

Looking ahead, the interplay between trade policy, standards development, and end-user expectations will continue to shape the adoption curve. Organizations that integrate technical, operational, and commercial perspectives into coherent go-to-market plans will reduce time-to-adoption and increase the likelihood that their innovations achieve lasting impact in critical sectors such as healthcare, transportation, and consumer electronics. Ultimately, success in this space depends on translating material performance into operational value propositions that are defensible, replicable, and aligned with evolving regulatory and procurement landscapes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Development of photoactive antiviral coatings using visible light activated nanocomposites for continuous surface disinfection
  • 5.2. Integration of durable antiviral polymer coatings into public transportation interior surfaces to reduce viral transmission
  • 5.3. Adoption of bio-based antiviral coatings derived from chitosan and other natural polymers for sustainable protection
  • 5.4. Emergence of self-healing antiviral coatings that restore efficacy after wear and abrasion in high traffic environments
  • 5.5. Use of metal oxide nanoparticles in antiviral coating formulations for enhanced broad spectrum activity and longevity
  • 5.6. Regulatory harmonization and global standard development for antiviral coating efficacy testing and certification protocols
  • 5.7. Customization of antiviral coatings for medical device surfaces with biocompatible and sterilizable performance properties
  • 5.8. Consumer electronics industry integration of transparent antiviral coatings for touchscreen disinfection without compromising sensitivity

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Antiviral Coatings Market, by Technology

  • 8.1. Copper
  • 8.2. Graphene Based
    • 8.2.1. Graphene Nanoplatelets
    • 8.2.2. Graphene Oxide
    • 8.2.3. Reduced Graphene Oxide
  • 8.3. Quaternary Ammonium Compound
  • 8.4. Silver Ion
  • 8.5. Titanium Dioxide
    • 8.5.1. Anatase
    • 8.5.2. Rutile

9. Antiviral Coatings Market, by Application

  • 9.1. Consumer Electronics
  • 9.2. Food & Beverage Packaging
  • 9.3. Healthcare
  • 9.4. HVAC Systems
  • 9.5. Transportation

10. Antiviral Coatings Market, by End User Industry

  • 10.1. Aerospace Industry
  • 10.2. Automotive Industry
  • 10.3. Commercial Buildings
  • 10.4. Food Processing Plants
  • 10.5. Hospitals & Clinics
  • 10.6. Residential Buildings

11. Antiviral Coatings Market, by Form

  • 11.1. Liquid Coating
  • 11.2. Powder Coating
  • 11.3. Self-Cleaning Film
  • 11.4. Spray Coating

12. Antiviral Coatings Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Retail

13. Antiviral Coatings Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Antiviral Coatings Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Antiviral Coatings Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. PPG Industries, Inc.
    • 16.3.2. The Sherwin-Williams Company
    • 16.3.3. Akzo Nobel N.V.
    • 16.3.4. Dow Inc.
    • 16.3.5. BASF SE
    • 16.3.6. DuPont de Nemours, Inc.
    • 16.3.7. RPM International Inc.
    • 16.3.8. Nippon Paint Holdings Co., Ltd.
    • 16.3.9. Kansai Paint Co., Ltd.
    • 16.3.10. Axalta Coating Systems Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ANTIVIRAL COATINGS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ANTIVIRAL COATINGS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANTIVIRAL COATINGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY COPPER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY COPPER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY COPPER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY COPPER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY COPPER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY COPPER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE NANOPLATELETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE NANOPLATELETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE NANOPLATELETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE NANOPLATELETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE NANOPLATELETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE NANOPLATELETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE OXIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE OXIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE OXIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE OXIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE OXIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE OXIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY REDUCED GRAPHENE OXIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY REDUCED GRAPHENE OXIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY REDUCED GRAPHENE OXIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY REDUCED GRAPHENE OXIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY REDUCED GRAPHENE OXIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY REDUCED GRAPHENE OXIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SILVER ION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SILVER ION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SILVER ION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SILVER ION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SILVER ION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SILVER ION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY ANATASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY ANATASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY ANATASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY ANATASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY ANATASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY ANATASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY RUTILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY RUTILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY RUTILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY RUTILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY RUTILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY RUTILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY CONSUMER ELECTRONICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY CONSUMER ELECTRONICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY CONSUMER ELECTRONICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY CONSUMER ELECTRONICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY CONSUMER ELECTRONICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY CONSUMER ELECTRONICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FOOD & BEVERAGE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FOOD & BEVERAGE PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FOOD & BEVERAGE PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FOOD & BEVERAGE PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FOOD & BEVERAGE PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FOOD & BEVERAGE PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HVAC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HVAC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HVAC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HVAC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HVAC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HVAC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TRANSPORTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TRANSPORTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TRANSPORTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TRANSPORTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY TRANSPORTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY AEROSPACE INDUSTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY AEROSPACE INDUSTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY AEROSPACE INDUSTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY AEROSPACE INDUSTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY AEROSPACE INDUSTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY AEROSPACE INDUSTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY AUTOMOTIVE INDUSTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY AUTOMOTIVE INDUSTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY AUTOMOTIVE INDUSTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY AUTOMOTIVE INDUSTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY AUTOMOTIVE INDUSTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY AUTOMOTIVE INDUSTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY COMMERCIAL BUILDINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY COMMERCIAL BUILDINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY COMMERCIAL BUILDINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY COMMERCIAL BUILDINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY COMMERCIAL BUILDINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY COMMERCIAL BUILDINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FOOD PROCESSING PLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FOOD PROCESSING PLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FOOD PROCESSING PLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FOOD PROCESSING PLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FOOD PROCESSING PLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FOOD PROCESSING PLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY RESIDENTIAL BUILDINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY RESIDENTIAL BUILDINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY RESIDENTIAL BUILDINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY RESIDENTIAL BUILDINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY RESIDENTIAL BUILDINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY RESIDENTIAL BUILDINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY LIQUID COATING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY LIQUID COATING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY LIQUID COATING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY LIQUID COATING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY LIQUID COATING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY LIQUID COATING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY POWDER COATING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY POWDER COATING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY POWDER COATING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY POWDER COATING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY POWDER COATING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY POWDER COATING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SELF-CLEANING FILM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SELF-CLEANING FILM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SELF-CLEANING FILM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SELF-CLEANING FILM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SELF-CLEANING FILM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SELF-CLEANING FILM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SPRAY COATING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SPRAY COATING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SPRAY COATING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SPRAY COATING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SPRAY COATING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY SPRAY COATING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2018-2024 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 312. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY END USER INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC ANTIVIRAL COATINGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 318. GLOBAL ANTIVIRAL COATINGS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 319. ASEAN ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. ASEAN ANTIVIRAL COATINGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. ASEAN ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 322. ASEAN ANTIVIRAL COATINGS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 323. ASEAN ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2018-2024 (USD MILLION)
  • TABLE 324. ASEAN ANTIVIRAL COATINGS MARKET SIZE, BY GRAPHENE BASED, 2025-2032 (USD MILLION)
  • TABLE 325. ASEAN ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2018-2024 (USD MILLION)
  • TABLE 326. ASEAN ANTIVIRAL COATINGS MARKET SIZE, BY TITANIUM DIOXIDE, 2025-2032 (USD MILLION)

TABLE 3